Inspectors found 111 open tickets for software defects categorized as catastrophic or severe patient harm. Several safety ...

BD will pay a civil penalty to resolve charges it misled investors about risks associated with sales of its Alaris infusion pump, the Securities and Exchange Commission said.

The FDA has issued a warning letter related to BD Pyxis automated medication dispensing systems — technology that was part of ...

BD (NYSE: BDX) announced that it reached an agreement with the SEC to resolve an investigation related to its Alaris system.

Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following ...

Becton Dickinson has agreed to pay a $175 million fine to settle an investigation by the U.S. Securities and Exchange Commission. The previously disclosed investigation was related to the medical ...

Becton, Dickinson and Co. reached an agreement with the U.S. Securities and Exchange Commission (SEC) to resolve an investigation related to allegations that the company misled investors regarding the ...

which was acquired by BD from CareFusion in 2015 and is part of the BD Medication Management Solutions business. The SEC Order, the findings of which BD neither admits nor denies, relate to ...

which was acquired by BD from CareFusion in 2015 and is part of the BD Medication Management Solutions business.